Which ETFs hold Novo Nordisk A/S (NOVOB)?
Danish drugmaker known for diabetes and obesity medicines including Ozempic and Wegovy.
24 Australian ETFs hold Novo Nordisk A/S, a Health Care company from DK. DRUG has the biggest weighting at 2.00%. Across these funds, Australian ETF investors own about $169m of Novo Nordisk A/S.
The ETFs with the most Novo Nordisk A/S
All 24 ETFs that hold Novo Nordisk A/S, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Novo Nordisk A/S.
Common questions
Which ETF has the most Novo Nordisk A/S?
DRUG (Betashares Global Healthcare Currency Hedged ETF) has the highest weighting, with 2.00% of the fund in Novo Nordisk A/S.
What is the cheapest ETF that holds Novo Nordisk A/S?
Of the ETFs where Novo Nordisk A/S is at least 1% of the fund, HLTH has the lowest fee at 0.45% a year, with 1.74% in Novo Nordisk A/S.
How much Novo Nordisk A/S do I own with $10,000 in VGS?
About $14. VGS is the largest ETF that holds Novo Nordisk A/S, and Novo Nordisk A/S makes up 0.14% of it.
How many Australian ETFs hold Novo Nordisk A/S?
24 ETFs listed on the ASX or TMX Australia hold Novo Nordisk A/S, based on issuers' published holdings.